Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane

Acta Pharmacologica Sinica

Volumn 27, Issue 1, 2006, Pages 66-70

  Li, Mu Feng ^a   Shi, Yu Liang ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Antibotulismic mechanism; Botulinum toxin type A; Ion channel; Single channel recording; Toosendanin

Indexed keywords

BOTULINUM TOXIN A; NEUROTOXIN; PROTEINASE; SNARE PROTEIN; TOOSENDANIN; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BOTULISM; CELL MEMBRANE; CELL STRAIN; CHANNEL GATING; CHINESE MEDICINE; CONTROLLED STUDY; ENZYME LOCALIZATION; LIGHT CHAIN; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PARALYSIS; PATCH CLAMP; PRESYNAPTIC NERVE; PROTEIN DEGRADATION; RAT;

ANIMALS; BOTULINUM TOXIN TYPE A; CELL MEMBRANE; DRUGS, CHINESE HERBAL; ION CHANNELS; MELIA; PC12 CELLS; PLANTS, MEDICINAL; PROTEIN TRANSPORT; RATS;

EID: 30144443994     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00236.x     Document Type: Article

References (27)

1. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 1986; 26: 427-53.
2. Swaminathan S, Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 2000; 7: 693-9.
3. Montecucco C, Papini E, Schiavo G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett 1994; 346: 92-8.
4. Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000; 80: 717-66.
5. - indicator: evidence for chloride accumulation during acidification. J Biol Chem 2002; 277: 5506-13.
6. Hoch DH, Romero-Mira M, Ehrlich BE, Finkelstein A, DasGupta BR, Simpson LL, et al. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Natl Acad Sci USA 1985; 82: 1692-6.
7. Donovan JJ, Middlebrook JL. Ion-conducting channels produced by botulinum toxin in planar lipid membranes. Biochemistry 1986; 25: 2872-6.
8. Blaustein RO, Germann WJ, Finkelstein A, DasGupta BR. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett 1987; 226: 115-20.
9. Schmid A, Benz R, Just I, Aktories K. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes. Formation of cation-selective channels and inhibition of channel function by chloroquine. J Biol Chem 1994; 269: 16706-11.
10. Sheridan RE. Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon 1998; 36: 703-17.
11. 1 Koriazova LK, Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 2003; 10: 13-8.
12. Chang CC, Hsie TH, Chen SF, Liang HT. The structure of chuanliansu. Acta Chem Sin 1975; 33: 35-47.
13. Shu GX, Liang XT. A correction of the structure of chuanliansu. Acta Chem Sin 1980; 38: 196-8.
14. Wang YB, Wen YX. A comprehensive report on clinical ascaris anthelmintic therapeutic effect of toosendanin pills. J Tradit Chin Med 1959; 262: 46-9.
15. Li PZ, Zhou J, Miao WY, Ding FH, Meng JY, Ye HJ, et al. Therapeutic effect of toosendanin on animal botulism. Tradit Herb Drugs 1982; 13: 28-30.Chinese.
16. Shi YL, Wang ZF. Cure of experimental botulism and antibotulismic effect of toosendanin. Acta Pharmacol Sin 2004; 25: 839-48.
17. Shi YL, Xu K. Antibotulismic effect of toosendanin. Chin Sci Bull 1983; 28: 885-7.
18. Zhou JY, Wang ZF, Ren XM, Tang MZ, Shi YL. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin. FEBS Lett 2003; 555: 375-9.
19. Ray P, Berman JD, Middleton W, Brendle J. Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells. J Biol Chem 1993; 268: 11057-64.
20. Hu Q, Huang FS, Shi YL. Inhibition of toosendanin on the delayed rectifier potassium current in neuroblastomaxglioma NG108-15 cells. Brain Res 1997; 751: 47-53.
21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981; 391: 85-100.
22. Simpson LL. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J Pharmacol Exp Ther 1983; 225: 546-52.
23. Simpson LL, Coffield JA, Bakry N. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J Pharmacol Exp Ther 1994; 269: 256-62.
24. + channels in hippocampal neurons by toosendanin. Neuroscience 2001; 104: 41-7.
25. Wang ZF, Shi YL. Toosendanin-induced inhibition of small-conductance calcium-activated potassium channels in CA1 pyramidal neurons of rat hippocampus. Neurosci Lett 2001; 303: 13-6.
26. Wang ZF, Shi YL. Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker. Neurosci Res 2001; 40: 211-5.
27. 2+ channels in NG108-15 cells. Toxicon 2004; 45: 53-60.